Catalyst Pharmaceuticals (CPRX) Leases: 2019-2025
Historic Leases for Catalyst Pharmaceuticals (CPRX) over the last 7 years, with Sep 2025 value amounting to $2.0 million.
- Catalyst Pharmaceuticals' Leases fell 12.65% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 million, marking a year-over-year decrease of 12.65%. This contributed to the annual value of $2.2 million for FY2024, which is 11.08% down from last year.
- Latest data reveals that Catalyst Pharmaceuticals reported Leases of $2.0 million as of Q3 2025, which was down 3.55% from $2.1 million recorded in Q2 2025.
- Catalyst Pharmaceuticals' Leases' 5-year high stood at $3.3 million during Q1 2021, with a 5-year trough of $2.0 million in Q3 2025.
- In the last 3 years, Catalyst Pharmaceuticals' Leases had a median value of $2.4 million in 2024 and averaged $2.4 million.
- Per our database at Business Quant, Catalyst Pharmaceuticals' Leases soared by 25,321.22% in 2021 and then dropped by 12.65% in 2025.
- Catalyst Pharmaceuticals' Leases (Quarterly) stood at $3.0 million in 2021, then dropped by 8.19% to $2.8 million in 2022, then dropped by 9.46% to $2.5 million in 2023, then decreased by 11.08% to $2.2 million in 2024, then decreased by 12.65% to $2.0 million in 2025.
- Its last three reported values are $2.0 million in Q3 2025, $2.1 million for Q2 2025, and $2.2 million during Q1 2025.